An engineered Cas9 fusion protein for the treatment of Gaucher disease type 1
Gaucher disease is a genetic disorder caused by point mutations in the GBA gene encoding for glucocerebrosidase, an enzyme that breaks down the fat glucocerebroside. This work proposes the...
